257 related articles for article (PubMed ID: 24297176)
41. Withaferin A induced impaired autophagy and unfolded protein response in human breast cancer cell-lines MCF-7 and MDA-MB-231.
Ghosh K; De S; Mukherjee S; Das S; Ghosh AN; Sengupta SB
Toxicol In Vitro; 2017 Oct; 44():330-338. PubMed ID: 28782635
[TBL] [Abstract][Full Text] [Related]
42. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells.
Zhao L; Miao HC; Li WJ; Sun Y; Huang SL; Li ZY; Guo QL
Mol Carcinog; 2016 May; 55(5):778-92. PubMed ID: 25945460
[TBL] [Abstract][Full Text] [Related]
43. Cytoprotective autophagy induction by withaferin A in prostate cancer cells involves GABARAPL1.
Hahm ER; Singh SV
Mol Carcinog; 2020 Oct; 59(10):1105-1115. PubMed ID: 32743846
[TBL] [Abstract][Full Text] [Related]
44. Withaferin A inhibits breast cancer-induced osteoclast differentiation.
Hahm ER; Kim SH; Singh SV
Mol Carcinog; 2023 Jul; 62(7):1051-1061. PubMed ID: 37067392
[TBL] [Abstract][Full Text] [Related]
45. Withaferin A targets heat shock protein 90 in pancreatic cancer cells.
Yu Y; Hamza A; Zhang T; Gu M; Zou P; Newman B; Li Y; Gunatilaka AA; Zhan CG; Sun D
Biochem Pharmacol; 2010 Feb; 79(4):542-51. PubMed ID: 19769945
[TBL] [Abstract][Full Text] [Related]
46. Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extract.
Patil D; Gautam M; Mishra S; Karupothula S; Gairola S; Jadhav S; Pawar S; Patwardhan B
J Pharm Biomed Anal; 2013 Jun; 80():203-12. PubMed ID: 23584079
[TBL] [Abstract][Full Text] [Related]
47. Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms.
Royston KJ; Paul B; Nozell S; Rajbhandari R; Tollefsbol TO
Exp Cell Res; 2018 Jul; 368(1):67-74. PubMed ID: 29689276
[TBL] [Abstract][Full Text] [Related]
48. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers.
Cohen SM; Mukerji R; Timmermann BN; Samadi AK; Cohen MS
Am J Surg; 2012 Dec; 204(6):895-900; discussion 900-1. PubMed ID: 23231932
[TBL] [Abstract][Full Text] [Related]
49. Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells.
Gu M; Yu Y; Gunaherath GM; Gunatilaka AA; Li D; Sun D
Invest New Drugs; 2014 Feb; 32(1):68-74. PubMed ID: 23887853
[TBL] [Abstract][Full Text] [Related]
50. Withaferin A inhibits the proliferation of gastric cancer cells by inducing G2/M cell cycle arrest and apoptosis.
Kim G; Kim TH; Hwang EH; Chang KT; Hong JJ; Park JH
Oncol Lett; 2017 Jul; 14(1):416-422. PubMed ID: 28693185
[TBL] [Abstract][Full Text] [Related]
51. Implications of Withaferin-A for triple-negative breast cancer chemoprevention.
Mallipeddi H; Thyagarajan A; Sahu RP
Biomed Pharmacother; 2021 Feb; 134():111124. PubMed ID: 33434782
[TBL] [Abstract][Full Text] [Related]
52. Antiproliferation potential of withaferin A on human osteosarcoma cells via the inhibition of G2/M checkpoint proteins.
Lv TZ; Wang GS
Exp Ther Med; 2015 Jul; 10(1):323-329. PubMed ID: 26170956
[TBL] [Abstract][Full Text] [Related]
53. Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera.
Joshi P; Misra L; Siddique AA; Srivastava M; Kumar S; Darokar MP
Steroids; 2014 Jan; 79():19-27. PubMed ID: 24184562
[TBL] [Abstract][Full Text] [Related]
54. Withaferin A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells.
Roy RV; Suman S; Das TP; Luevano JE; Damodaran C
J Nat Prod; 2013 Oct; 76(10):1909-15. PubMed ID: 24079846
[TBL] [Abstract][Full Text] [Related]
55. Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.
Okamoto S; Tsujioka T; Suemori S; Kida J; Kondo T; Tohyama Y; Tohyama K
Cancer Sci; 2016 Sep; 107(9):1302-14. PubMed ID: 27311589
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A.
Zhang X; Samadi AK; Roby KF; Timmermann B; Cohen MS
Gynecol Oncol; 2012 Mar; 124(3):606-12. PubMed ID: 22188785
[TBL] [Abstract][Full Text] [Related]
57. Methyl 5-[(1H-indol-3-yl)selanyl]-1H-benzoimidazol-2-ylcarbamate (M-24), a novel tubulin inhibitor, causes G2/M arrest and cell apoptosis by disrupting tubulin polymerization in human cervical and breast cancer cells.
Zuo D; Jiang X; Han M; Shen J; Lang B; Guan Q; Bai Z; Han C; Li Z; Zhang W; Wu Y
Toxicol In Vitro; 2017 Aug; 42():139-149. PubMed ID: 28412508
[TBL] [Abstract][Full Text] [Related]
58. Determination of permeability, plasma protein binding, blood partitioning, pharmacokinetics and tissue distribution of Withanolide A in rats: A neuroprotective steroidal lactone.
Singh SK; Valicherla GR; Joshi P; Shahi S; Syed AA; Gupta AP; Hossain Z; Italiya K; Makadia V; Singh SK; Wahajuddin M; Gayen JR
Drug Dev Res; 2018 Nov; 79(7):339-351. PubMed ID: 30284738
[TBL] [Abstract][Full Text] [Related]
59. Synergistic interaction of N-3-Br-benzyl-noscapine and docetaxel abrogates oncogenic potential of breast cancer cells.
Dash SG; Kantevari S; Pandey SK; Naik PK
Chem Biol Drug Des; 2021 Sep; 98(3):466-479. PubMed ID: 34107169
[TBL] [Abstract][Full Text] [Related]
60. Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity.
Appierto V; Tiberio P; Cavadini E; Casalini P; Cappelletti G; Formelli F
Mol Cancer Ther; 2009 Dec; 8(12):3360-8. PubMed ID: 19996280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
